Capstone Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,445
| Closed | -$804K | – | 1654 |
|
|
2025
Q4 | $857K | Sell |
2,445
-5,334
| -69% | -$1.8M | ﹤0.01% | 926 |
|
|
2025
Q3 | $2.51M | Buy |
7,779
+5,460
| +235% | +$1.7M | ﹤0.01% | 687 |
|
|
2025
Q2 | $902K | Buy |
2,319
+909
| +64% | +$366K | ﹤0.01% | 896 |
|
|
2025
Q1 | $613K | Sell |
1,410
-19,276
| -93% | -$7.74M | ﹤0.01% | 1026 |
|
|
2024
Q4 | $7.63M | Buy |
20,686
+17,613
| +573% | +$7.37M | 0.02% | 416 |
|
|
2024
Q3 | $1.6M | Buy |
3,073
+583
| +23% | +$311K | ﹤0.01% | 813 |
|
|
2024
Q2 | $1.35M | Sell |
2,490
-3,165
| -56% | -$1.67M | ﹤0.01% | 864 |
|
|
2024
Q1 | $2.93M | Buy |
5,655
+1,816
| +47% | +$903K | 0.01% | 625 |
|
|
2023
Q4 | $1.81M | Sell |
3,839
-2,474
| -39% | -$1.14M | 0.01% | 840 |
|
|
2023
Q3 | $2.75M | Sell |
6,313
-350
| -5% | -$159K | 0.01% | 615 |
|
|
2023
Q2 | $2.96M | Buy |
6,663
+2,859
| +75% | +$1.32M | 0.01% | 524 |
|
|
2023
Q1 | $1.75M | Buy |
+3,804
| New | +$1.81M | 0.01% | 635 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | -$6.6K | – | 1555 |
|
|
2022
Q3 | $6K | Sell |
13
-835
| -98% | -$400K | ﹤0.01% | 1637 |
|
|
2022
Q2 | $409K | Sell |
848
-3,887
| -82% | -$1.92M | ﹤0.01% | 1296 |
|
|
2022
Q1 | $2.33M | Sell |
4,735
-2,779
| -37% | -$1.27M | 0.01% | 988 |
|
|
2021
Q4 | $3.48M | Sell |
7,514
-1,975
| -21% | -$831K | 0.01% | 937 |
|
|
2021
Q3 | $3.54M | Buy |
9,489
+4,742
| +100% | +$1.8M | 0.01% | 973 |
|
|
2021
Q2 | $1.81M | Buy |
+4,747
| New | +$1.81M | ﹤0.01% | 1067 |
|
|
2020
Q4 | – | Sell |
-17,271
| Closed | -$5.3M | – | 1687 |
|
|
2020
Q3 | $4.64M | Buy |
17,271
+5,832
| +51% | +$1.57M | 0.02% | 536 |
|
|
2020
Q2 | $3.01M | Sell |
11,439
-8,615
| -43% | -$2.3M | 0.02% | 579 |
|
|
2020
Q1 | $4.55M | Buy |
+20,054
| New | +$5.47M | 0.07% | 297 |
|
|
2019
Q4 | – | Sell |
-24,317
| Closed | -$6.69M | – | 1395 |
|
|
2019
Q3 | $5.84M | Buy |
24,317
+14,309
| +143% | +$3.92M | 0.04% | 397 |
|
|
2019
Q2 | $2.82M | Buy |
10,008
+4,014
| +67% | +$1.1M | 0.02% | 646 |
|
|
2019
Q1 | $1.72M | Sell |
5,994
-707
| -11% | -$204K | 0.02% | 658 |
|
|
2018
Q4 | $1.76M | Buy |
6,701
+4,837
| +259% | +$1.33M | 0.02% | 470 |
|
|
2018
Q3 | $511K | Buy |
1,864
+432
| +30% | +$112K | 0.01% | 793 |
|
|
2018
Q2 | $341K | Buy |
+1,432
| New | +$332K | 0.01% | 522 |
|
|
2017
Q1 | – | Sell |
-8,300
| Closed | -$1.19M | – | 945 |
|
|
2016
Q4 | $1.19M | Buy |
8,300
+4,900
| +144% | +$656K | 0.04% | 371 |
|
|
2016
Q3 | $426K | Sell |
3,400
-18,154
| -84% | -$2.34M | 0.01% | 538 |
|
|
2016
Q2 | $2.83M | Buy |
+21,554
| New | +$2.95M | 0.05% | 196 |
|
Other funds holding ELV
VCM
VPM
Capstone Investment Advisors's ELV Position: Q1 2026 in Review
Capstone Investment Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 2,445 shares — an estimated $804K sold.
Capstone Investment Advisors first reported a position in ELV in Q2 2016 and held it in 30 quarters. The position peaked at $7.63M in Q4 2024. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Capstone Investment Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 2,445 Elevance Health shares in Q1 2026, an estimated $804K.
- Capstone Investment Advisors first reported a position in Elevance Health in Q2 2016 and held it in 30 quarters.
- Capstone Investment Advisors's Elevance Health position peaked at $7.63M in Q4 2024.
- 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.